A single dose of RSV vaccine is recommended for all Aboriginal and Torres Strait Islander adults aged ≥60 years. The burden of RSV disease is significantly higher in Aboriginal and Torres Strait Islander people than in non-Indigenous adults. For example, the RSV-related hospitalisation rate at 60 years of age in Aboriginal and Torres Strait Islander adults is comparable to the rate in non-Indigenous adults at 75 years of age.
RSV vaccine may be given at any time of the year but, where possible, should be offered before the start of the RSV season.
Either Abrysvo or Arexvy may be used, with no brand preference.
Protection lasts for at least 2 years, and the need for further doses has not been established.
